通達股份(002560.SZ):預中標1.12億元國家電網採購項目
格隆匯5月23日丨通達股份(002560.SZ)公佈,國家電網公司電子商務平台於近日在“招標採購\推薦中標候選人公示”中發佈了《國家電網有限公司2022年第十六批採購(輸變電項目第二次線路裝置性材料招標採購)推薦的中標候選人公示》、《國家電網有限公司2022年第十八批採購(輸變電項目第一次35-330千伏材料協議庫存招標採購)推薦的中標候選人公示》和《國網江西省電力有限公司2022年第一次配網(省網)協議庫存物資公開招標採購項目中標候選人名單公示》,公示開始時間均為2022年5月20日,公示期3日。據公司測算,上述中標物資總價值共計約人民幣1.12億元,約佔公司2021年度營業總收入的4.75%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.